![2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Journal of the American College of Cardiology 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/f258d51c-8d22-4571-bc0e-1a9dbf4ec27e/fx1.jpg)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Journal of the American College of Cardiology
![Implementation of Cardiovascular Screening in Hispanic Patient Population with RA, SLE and PsA - ACR Meeting Abstracts Implementation of Cardiovascular Screening in Hispanic Patient Population with RA, SLE and PsA - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2019/08/GTUOHVCE-699646-2-ANY.png)
Implementation of Cardiovascular Screening in Hispanic Patient Population with RA, SLE and PsA - ACR Meeting Abstracts
![PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA 'Pooled Cohort' Equations | tctmd.com PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA 'Pooled Cohort' Equations | tctmd.com](https://d18mqtxkrsjgmh.cloudfront.net/public/2018-05/5.10.18%20PREDICT-1%C2%B0%20CVD%20Risk%20Calculator%2C%20Based%20on%20Present-Day%20Patients.jpg)
PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA 'Pooled Cohort' Equations | tctmd.com
![2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Journal of the American College of Cardiology 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/c998559d-5ed6-4ba3-b90e-a800fdc19b33/j.jacc.2013.11.005.fp.png)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Journal of the American College of Cardiology
![2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation](https://www.ahajournals.org/cms/asset/becf86f4-6945-4237-b27f-00d17f2b87c5/e563tab05.gif)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation
![MedGenome on Twitter: "American Heart Association (AHA) has released a scientific statement on Polygenic Risk Scores for CVD - It highlights the role of Polygenic Risk Score (PRS) when integrated with AHA / MedGenome on Twitter: "American Heart Association (AHA) has released a scientific statement on Polygenic Risk Scores for CVD - It highlights the role of Polygenic Risk Score (PRS) when integrated with AHA /](https://pbs.twimg.com/media/FahKwWwakAUaDm3.jpg:large)
MedGenome on Twitter: "American Heart Association (AHA) has released a scientific statement on Polygenic Risk Scores for CVD - It highlights the role of Polygenic Risk Score (PRS) when integrated with AHA /
![The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease. | Semantic Scholar The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e291ffeb2be42def4d2b8fc29877631eba1432b9/3-Table1-1.png)
The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease. | Semantic Scholar
![Heart Disease and Stroke Statistics - 2023 Update - Professional Heart Daily | American Heart Association Heart Disease and Stroke Statistics - 2023 Update - Professional Heart Daily | American Heart Association](https://professional.heart.org/-/media/PHD-Images/Science-News/h/e/heart_disease_stroke_stats_2023_update.jpg)
Heart Disease and Stroke Statistics - 2023 Update - Professional Heart Daily | American Heart Association
![ACC/AHA 2013 and SCORE CV Risk Calculators: Are They the Same in a Low-Risk Southern European Population? - American College of Cardiology ACC/AHA 2013 and SCORE CV Risk Calculators: Are They the Same in a Low-Risk Southern European Population? - American College of Cardiology](https://www.acc.org/-/media/Non-Clinical/Images/Latest-in-Cardiology/Articles/2015/03/EA_2015Mar02_Santos_Figure3.png?la=en&hash=0A4559C84F77E6EB41B3C9170BD36D162EBDBE33)
ACC/AHA 2013 and SCORE CV Risk Calculators: Are They the Same in a Low-Risk Southern European Population? - American College of Cardiology
![Machine Learning Outperforms ACC/AHA CVD Risk Calculator in MESA | Journal of the American Heart Association Machine Learning Outperforms ACC/AHA CVD Risk Calculator in MESA | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/5a35f986-738d-44ea-986c-002ad06e8fc4/jah33407-fig-0003.png)
Machine Learning Outperforms ACC/AHA CVD Risk Calculator in MESA | Journal of the American Heart Association
![Comparison of two cardiovascular risk assessment tools to determine appropriate use of aspirin as primary prevention for patients with type 2 diabetes. - ppt download Comparison of two cardiovascular risk assessment tools to determine appropriate use of aspirin as primary prevention for patients with type 2 diabetes. - ppt download](https://slideplayer.com/8583322/26/images/slide_1.jpg)
Comparison of two cardiovascular risk assessment tools to determine appropriate use of aspirin as primary prevention for patients with type 2 diabetes. - ppt download
![2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation](https://www.ahajournals.org/cms/asset/f80f6831-167a-4879-b2eb-65d36df1665d/e596tab03.gif)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation
![Risk Assessment for Cardiovascular Disease with Nontraditional Risk Factors: Recommendation Statement | AAFP Risk Assessment for Cardiovascular Disease with Nontraditional Risk Factors: Recommendation Statement | AAFP](https://www.aafp.org/content/dam/brand/aafp/pubs/afp/issues/2019/0115/od1-t1.gif)